BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Overall survival and rate of cumulative incidence (CI) of CML‐related death were significantly correlated with the disease phase at the time of mutation analysis (CP vs AP‐BP) whatever the presence or absence of a BCR‐ABL KD mutation (Figure 2).